Evidence map›Paper›PMID 35745770›Full record

ArticlePharmaceutics2022

Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications.

Zhen Li, Shunqi Mei, Yajie Dong, Fenghua She, Chengpeng Li, Yongzhen Li, Lingxue Kong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Tobramycin Nanoantibiotics and Their Advantages: A Minireview.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhen LiInstitute for Frontier Materials, Deakin University, Geelong, VIC 3216, Australia.ORCID 0000-0002-7689-0439
Shunqi MeiHubei Digital Textile Equipment Key Laboratory, Wuhan Textile University, Wuhan 430073, China.
Yajie DongInstitute for Frontier Materials, Deakin University, Geelong, VIC 3216, Australia.
Fenghua SheInstitute for Frontier Materials, Deakin University, Geelong, VIC 3216, Australia.
Chengpeng LiAgricultural Product Processing Research Institute, Chinese Academy of Tropical Agricultural Sciences, Zhanjiang 524001, China.
Yongzhen LiAgricultural Product Processing Research Institute, Chinese Academy of Tropical Agricultural Sciences, Zhanjiang 524001, China.ORCID 0000-0002-2990-3655
Lingxue KongInstitute for Frontier Materials, Deakin University, Geelong, VIC 3216, Australia.ORCID 0000-0001-6219-3897

Funding

Central Public-Interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences 1630122017010National Natural Science Foundation of China 51175385Science and Technology Program of Hubei Province 2018AAA036Science and Technology Program of Hubei Province 2019AEE011
6 · The paper itself

Abstract

Chitosan (CS) is a biodegradable, biocompatible, and non-toxic natural amino-poly-saccharide with antibacterial ability, owing to its positively charged amino groups. However, the low charge density leads to poor antibacterial efficiency which cannot meet the biomedical application requirements. In this study, Tobramycin (TOB) was grafted onto the backbone of oxidized chitosan (OCS) to synthesize oxidized chitosan-tobramycin (OCS-TOB). FTIR,

Indexed as

biomedical applicationcentrifugal spinningchitosansubmicro-fiberstobramycin

Identifiers

PMID35745770
PMCPMC9227200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.